Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Kent

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|July 2, 2020
4-month-old boy coinfected with COVID-19 and adenovirusKelsey Danley, Paul Kent
Global Pediatric Health|July 2, 2019
The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for ManagementAnil P George, Paul Kent
Pediatric Blood & Cancer|June 1, 2005
New anticoagulants in pediatricsPaul Kent, Leonard A Valentino
Journal of Clinical Medicine|April 3, 2021
What Effect Do Pulmonary Micronodules Detected at Presentation in Patients with Osteosarcoma Have on 5-Year Overall Survival?Reid Davison, Fadi Hamati, Paul Kent
The New England Journal of Medicine|January 6, 2012
Case 26-2011: A boy with a complex kidney cystPaul Kent, Cesar Ochoa, Natasha Rajabali
The New England Journal of Medicine|April 11, 2009
Case 3-2009: a 9-month-old boy with seizuresPaul Kent, Becky Smeraglinolo, Doan Le
Journal of Pediatric Hematology/Oncology|March 8, 2017
Osteosarcoma Metastases With Direct Cardiac Invasion: A Case Report and Review of the Pediatric LiteratureRobert Hartemayer, Christopher Kuo, Paul Kent
Journal of Pediatric Hematology/Oncology|December 14, 2005
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literatureRoss Fasano, Paul Kent, Leonard Valentino
Oncology|March 10, 2021
Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with High-Risk Fibrolamellar CarcinomaSara Gottlieb, Claire O'Grady, Ariel Gliksberg, et al.
Plos Computational Biology|April 20, 2023
Ten simple rules for working with other people's codeCharlie Pilgrim, Paul Kent, Kasra Hosseini, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|July 2, 2020
4-month-old boy coinfected with COVID-19 and adenovirusKelsey Danley, Paul Kent
Global Pediatric Health|July 2, 2019
The Impact of Multiple Risk Factors for Venous Thromboembolism and Its Implications for ManagementAnil P George, Paul Kent
Pediatric Blood & Cancer|June 1, 2005
New anticoagulants in pediatricsPaul Kent, Leonard A Valentino
Journal of Clinical Medicine|April 3, 2021
What Effect Do Pulmonary Micronodules Detected at Presentation in Patients with Osteosarcoma Have on 5-Year Overall Survival?Reid Davison, Fadi Hamati, Paul Kent
The New England Journal of Medicine|January 6, 2012
Case 26-2011: A boy with a complex kidney cystPaul Kent, Cesar Ochoa, Natasha Rajabali
The New England Journal of Medicine|April 11, 2009
Case 3-2009: a 9-month-old boy with seizuresPaul Kent, Becky Smeraglinolo, Doan Le
Journal of Pediatric Hematology/Oncology|March 8, 2017
Osteosarcoma Metastases With Direct Cardiac Invasion: A Case Report and Review of the Pediatric LiteratureRobert Hartemayer, Christopher Kuo, Paul Kent
Journal of Pediatric Hematology/Oncology|December 14, 2005
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literatureRoss Fasano, Paul Kent, Leonard Valentino
Oncology|March 10, 2021
Early Experiences with Triple Immunochemotherapy in Adolescents and Young Adults with High-Risk Fibrolamellar CarcinomaSara Gottlieb, Claire O'Grady, Ariel Gliksberg, et al.
Plos Computational Biology|April 20, 2023
Ten simple rules for working with other people's codeCharlie Pilgrim, Paul Kent, Kasra Hosseini, et al.
Pageof 3